Results 31 to 40 of about 3,487 (207)

Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)

Frontiers in Aging Neuroscience, 2022
Myelin oligodendrocyte glycoprotein-IgG-associated disorder (MOGAD) is a nervous system (NS) demyelination disease and a newly recognized distinct disease complicated with various diseases or symptoms; however, MOGAD was once considered a subset of ...
Yunjie Li, Xia Liu, Jingxuan Wang, Chao Pan, Zhouping Tang   +4 more
doaj   +1 more source

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders

Frontiers in Neurology, 2023
Myelin oligodendrocyte glycoprotein (MOG) is expressed on the outermost layer of the myelin sheath in the central nervous system. Recently, the clinical concept of MOG antibody-associated disease (MOGAD) was established based on the results of human MOG ...
Yoshiki Takai, Tatsuro Misu, Kazuo Fujihara, Kazuo Fujihara, Masashi Aoki   +4 more
doaj   +1 more source

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22) [PDF]

Neurology Letters, 2023
Patients with Myelin Oligodendrocyte Glycoprotein (MOG)-IgG present with isolated optic neuritis or transverse myelitis, acute disseminated encephalomyelitis (ADEM), brainstem or cerebellar features, or cerebral cortical encephalitis.
Samaneh Hosseini
doaj  

Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report

BMC Neurology, 2022
Background Serum antibodies to myelin-oligodendrocyte glycoprotein (MOG) are biomarkers of MOG-IgG-associated disorder (MOGAD), a demyelinating disease distinct from both multiple sclerosis and aquaporin-4-IgG neuromyelitis optica spectrum disorder.
Jan Kolcava, Aneta Rajdova, Eva Vlckova, Pavel Stourac, Josef Bednarik   +4 more
doaj   +1 more source

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD

Frontiers in Immunology, 2022
Background and ObjectiveNeuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease (MOGAD) are autoimmune inflammatory demyelinating diseases of the central nervous system (CNS).
Liuyu Lin, Yuqing Wu, Hailun Hang, Jie Lu, Yuanliang Ding   +4 more
doaj   +1 more source

Acute Hemorrhagic Encephalomyelitis in the Context of MOG Antibody-Associated Disease. Comment on Chen et al. Rapid Progressive Fatal Acute Hemorrhagic Encephalomyelitis. Diagnostics 2023, 13, 2481

Diagnostics, 2023
The study by Chen et al. of a 56-year-old man diagnosed with acute hemorrhagic encephalomyelitis (AHEM) had a significant impact on us. The authors provided a comprehensive account of their diagnostic journey and emphasized the need to differentiate ...
Sohyeon Kim, Mi-Yeon Eun, Jae-Joon Lee, Hung Youl Seok   +3 more
doaj   +1 more source

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis

Scientific Reports, 2022
Optic neuritis (ON) is a frequent presentation at onset of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). The pathophysiology underlying these diseases,
Hadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, Alon Tiosano, Itay Lotan, Mark A. Hellmann, Adi Wilf-Yarkoni, Omer Bialer, Eoin P. Flanagan, Sean J. Pittock, M. Tariq Bhatti, Tanja Schmitz-Hübsch, Friedemann Paul, Susanna Asseyer, John J. Chen   +14 more
doaj   +1 more source

Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?

Frontiers in Immunology, 2021
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) covers a wide spectrum of manifestations and is defined by the presence of MOG seropositivity.
Yang Zheng, Meng-Ting Cai, Er-Chuang Li, Wei Fang, Chun-Hong Shen, Yin-Xi Zhang   +5 more
doaj   +1 more source

Complement Activation Is a Prominent Feature of MOGAD [PDF]

Annals of Neurology, 2021
Myelin oligodendrocyte glycoprotein (MOG)‐antibody (Ab)–associated diseases (MOGADs) account for a substantial proportion of pediatric and adult patients who present with acquired demyelinating disorders. Its pathogenesis and optimal therapy are incompletely understood.
Christian W. Keller, Joseph A. Lopez, Eva‐Maria Wendel, Sudarshini Ramanathan, Catharina C. Gross, Luisa Klotz, Markus Reindl, Russell C. Dale, Heinz Wiendl, Kevin Rostásy, Fabienne Brilot, Jan D. Lünemann   +11 more
openaire   +2 more sources

Mogad: abordaje diagnóstico y terapéutico [PDF]

, 2023
La enfermedad asociada a anticuerpos contra glicoproteínas de oligodendrocitos de mielina o MOGAD, es una patología inflamatoria autoinmune del sistema nervioso central, mediada por un proceso desmielinizante. Existen muy pocos datos sobre la prevalencia
Jaramillo Pizarro, Cyndi Karen
core   +1 more source